text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Gelieve het aantal te selecteren

c-Jun N-terminal kinase (JNK) Inhibitor: SU 3327

No.178(July 2018)
A2940
SU 3327 (1)
SU 3327 (1) is a JNK (c-Jun N-terminal kinase) inhibitor developed based on structure-activity relationship studies.1) 1 inhibits activating transcription factor-2 (AFT-2) phosphorylation by JNK1 with IC50 = 0.7 μM in a substrate competitive manner. 1 also inhibits protein-protein interaction between JNK and JIP-1* with IC50 = 239 nM.
As one of the important roles JNK plays in the induction of autophagy via stimulations as shown in Table 1. It has been demonstrated that acute ethanol treatment decreased autophagy in mouse models and the decrease in autophagy was prevented by 1.2)
* JIP-1: JNK-interacting proteins (JIP) were identified as JNK scaffold proteins.3,4) JIP1 is a member of the JIP family and contains a JNK binding domain (JBD), a SRC homology (SH3) domain, and phosphotyrosine-binding (PTB) domain. JBD possesses the consensus sequence, R/KXXXXLXL.5) The probe, pep-JIP1, used in the reference (1), contains the sequence.

Table 1. Autophagy by various stimuli implicating JNK

These products are for research purpose only.

References

The prices are subject to change without notice. Please confirm the newest price by our online catalog before placing an order.
In addition, sales products changes with areas. Please understand that a product is not available when the product details page is not displayed.
Sessiestatus
Uw sessie verloopt over 10 minuten. Na het verlopen van de sessie word u doorgestuurd naar de startpagina. Klik op de knop om de sessie vanaf dezelfde pagina voort te zetten. minuut. Na het verlopen van de sessie word u doorgestuurd naar de startpagina. Klik op de knop om de sessie vanaf dezelfde pagina voort te zetten.

Uw sessie is verlopen. U wordt doorgestuurd naar de startpagina.